Evidence
Clin Nutr ESPEN. 2024 Apr;60:240-246. doi: 10.1016/j.clnesp.2024.02.013. Epub 2024 Feb 19.
ABSTRACT
BACKGROUND & AIMS: Cirrhosis is associated with insulin resistance and impaired glucose tolerance, which may be caused by impairments at different tissue levels (liver, skeletal muscle, and/or beta cell).
METHODS: Here, glucose kinetics at whole-body and skeletal muscle level in patients with cirrhosis (Child-Pugh A and B) were studied during parenteral nutrition using the isotope dilution technique and arteriovenous balance approach across the leg. As opposed to the euglycemic hyperinsulinemic clamp or glucose tolerance tests applied in previous studies, this approach provides a nutrient composition more similar to a normal meal while circumventing any possible portal-systemic shunting, impaired hepatic uptake and incretin effect.
RESULTS: We confirmed the presence of hepatic and peripheral insulin resistance in our patient population. Endogenous glucose production was less suppressed in response to parenteral nutrition. However, glucose uptake in skeletal muscle was increased.
CONCLUSION: Our results suggests that in our study participants with cirrhosis, the hepatic and peripheral insulin resistance is compensated for by increased insulin secretion and thus, increased glucose uptake in muscle. Hereby, glucose homeostasis is maintained.
PMID:38479917 | DOI:10.1016/j.clnesp.2024.02.013
Estimated reading time: 4 minute(s)
Latest: Psychiatryai.com #RAISR4D Evidence
Cool Evidence: Engaging Young People and Students in Real-World Evidence
Real-Time Evidence Search [Psychiatry]
AI Research
Glucose turnover at whole-body and skeletal muscle level in response to parenteral nutrition in male patients with alcoholic liver cirrhosis
🌐 90 Days
AI Virtual Reality Related Evidence Matrix
- Depletion of TBC1D4 improves the metabolic exercise response by overcoming genetically induced peripheral insulin resistance
- Mid-arm muscle circumference cutoff points in patients with cirrhosis: Low muscle mass related to malnutrition predicts mortality
- Drp1 controls complex II assembly and skeletal muscle metabolism by Sdhaf2 action on mitochondria
- Sarcopenia in cirrhosis: Unraveling the prevalence and relationships with liver disease severity and complications
- Sarcopenia in cirrhosis: Unraveling the prevalence and relationships with liver disease severity and complications
- Muscle fibre morphometric analysis (MusMA) correlates with muscle function and cardiovascular risk prognosis
- Clinical Overview of Sarcopenia, Frailty, and Malnutrition in Patients With Liver Cirrhosis
- Adipose Tissue Insulin Resistance in South Asian and Nordic Women after Gestational Diabetes Mellitus
- From NAFLD to NASH: Understanding the spectrum of non-alcoholic liver diseases and their consequences
- Delineating the contribution of ageing and physical activity to changes in mitochondrial characteristics across the lifespan
- Fat loss and muscle gain: The possible role of cortical glutamate in determining the efficacy of physical exercise
- Long-Term pemafibrate treatment exhibits limited impact on body fat mass in patients with hypertriglyceridemia accompanying NAFLD
- Sex difference in skeletal muscle mass in relation to metabolic dysfunction-associated steatotic liver disease: a propensity score matching study
- MiR-18 regulates lipid metabolism of non-alcoholic fatty liver disease via IGF1
- Reduced exercise capacity occurs before intrinsic skeletal muscle dysfunction in experimental rat models of pulmonary hypertension
- Effectiveness of the ALT/AST ratio for predicting insulin resistance in a Korean population: A large-scale, cross-sectional cohort study
- Prevalence of nonalcoholic fatty liver disease and liver cirrhosis in Chinese adults with type 2 diabetes mellitus
- The influence of acute lifestyle changes on NAFLD evolution in a multicentre cohort: a matter of body composition
- Amisulpride as the antipsychotic of choice in severe psychotic disorder with comorbid impaired glucose tolerance
- Inflammatory liver diseases and susceptibility to sepsis
- Blood flow restriction Exercise in the perioperative setting to Prevent loss of muscle mass in patients with pancreatic, biliary tract, and liver cancer: study protocol for the PREV-Ex randomized controlled trial
- Blood flow restriction Exercise in the perioperative setting to Prevent loss of muscle mass in patients with pancreatic, biliary tract, and liver cancer: study protocol for the PREV-Ex randomized controlled trial
- 13C-Stable isotope resolved metabolomics uncovers dynamic biochemical landscape of gut microbiome-host organ communications in mice
- Effect of Zuogui Jiangtang Qinggan Formula on lipid metabolism in db/db mouse model of type 2 diabetes mellitus complicated with non-alcoholic fatty liver disease
- Circadian desynchrony and glucose metabolism
- Measurement plane of the cross-sectional area of the masseter muscle in patients with skeletal Class III malocclusion: An artificial intelligence model
- Efficacy, tolerability and pharmacokinetics of survodutide, a glucagon/glucagon-like peptide-1 receptor dual agonist, in cirrhosis
- Efficacy, tolerability and pharmacokinetics of survodutide, a glucagon/glucagon-like peptide-1 receptor dual agonist, in cirrhosis
- A comprehensive approach to lifestyle intervention based on a calorie-restricted diet ameliorates liver fat in overweight/obese patients with NAFLD: a multicenter randomized controlled trial in China
- Three-Dimensional Structure of Novel Liver Cancer Biomarker Liver Cancer-Specific Serine Protease Inhibitor Kazal (LC-SPIK) and Its Performance in Clinical Diagnosis of Hepatocellular Carcinoma (HCC)
- Hypercaloric low-carbohydrate high-fat diet protects against the development of nonalcoholic fatty liver disease in obese mice in contrast to isocaloric Western diet
- Effects of Tirzepatide vs Semaglutide on β-cell Function, Insulin Sensitivity, and Glucose Control During a Meal Test
- Characteristics of nuclear architectural abnormalities of myotubes differentiated from LmnaH222P/H222P skeletal muscle cells
- Automated CT Analysis of Body Composition as a Frailty Biomarker in Abdominal Surgery
- Relationship between changes in blood glucose, glycosylated hemoglobin [HbA1c], cholesterol, and triglyceride and changes in hepatic enzymes
- Burden of liver cancer attributable to high fasting plasma glucose: a global analysis based on the global burden of disease study 2019
- Burden of liver cancer attributable to high fasting plasma glucose: a global analysis based on the global burden of disease study 2019
- Food perception promotes phosphorylation of MFFS131 and mitochondrial fragmentation in liver
- Muscle strength and non-alcoholic fatty liver disease/metabolic-associated fatty liver disease
- The association between score of plant-based diet and non-alcoholic fatty liver disease in adults
- Abdominal CT metrics in 17,646 patients reveal associations between myopenia, myosteatosis, and medical phenotypes: a phenome-wide association study
- Body composition assessment by artificial intelligence can be a predictive tool for short-term postoperative complications in Hartmann's reversals
- Prevalence of Sarcopenia and Its Defining Components in Non-alcoholic Fatty Liver Disease Varies According to the Method of Assessment and Adjustment: Findings from the UK Biobank
- Xiaozhi Formula Attenuates Non-Alcoholic Fatty Liver Disease by Regulating Lipid Metabolism via Activation of AMPK and PPAR pathways
- Xiaozhi Formula Attenuates Non-Alcoholic Fatty Liver Disease by Regulating Lipid Metabolism via Activation of AMPK and PPAR pathways
- Triglyceride Glucose Index is Associated with Ultrasonographic Fatty Liver Indicator in Children and Adolescents with Non-alcoholic Fatty Liver Disease
- Incretin-based investigational therapies for the treatment of MASLD/MASH
- Associations between estimated glucose disposal rate and arterial stiffness and mortality among US adults with non-alcoholic fatty liver disease
- Associations between estimated glucose disposal rate and arterial stiffness and mortality among US adults with non-alcoholic fatty liver disease
- Muscle Quality as a Potential Diagnostic Marker of Advanced Liver Fibrosis in Patients with Non-alcoholic Fatty Liver Disease
- Association between the skeletal muscle mass to visceral fat area ratio and metabolic dysfunction-associated fatty liver disease: A cross-sectional study of NHANES 2017-2018
- Effectiveness of different tools for malnutrition in the assessment of patients with cirrhosis
- Genetic correlations between liver fat content, metabolic health, and adiposity distribution in the Fels Longitudinal Study
- Semaglutide combined with empagliflozin vs. monotherapy for non-alcoholic fatty liver disease in type 2 diabetes: Study protocol for a randomized clinical trial
- Outcome of individuals with alcoholic cirrhosis hospitalized with first decompensation and their predictors
- Feasibility and effectiveness of a distance-adapted physical activity intervention in adolescents with obesity during the COVID-19 pandemic
- Serum Vitamin D Level in Overweight Individuals and Its Correlation With the Incidence of Non-alcoholic Fatty Liver Disease
- Role of Angiotensin II in Non-Alcoholic Steatosis Development
- Semaglutide alters gut microbiota and improves NAFLD in db/db mice
- Clinical, experimental and pathophysiological effects of Yaq-001: a non-absorbab le, gut-restricted adsorbent in models and patients with cirrhosis
- Deuterium metabolic imaging differentiates glioblastoma metabolic subtypes and detects early response to chemoradiotherapy
- Malnutrition management and the application of medical nutrition therapy in hospitalized patients at the end of life
- ESPEN guideline on nutrition and hydration in dementia - Update 2024
- White Adipose Tissue in Metabolic Associated Fatty Liver Disease
Evidence Blueprint
Glucose turnover at whole-body and skeletal muscle level in response to parenteral nutrition in male patients with alcoholic liver cirrhosis
☊ AI-Driven Related Evidence Nodes
(recent articles with at least 5 words in title)
More Evidence
Glucose turnover at whole-body and skeletal muscle level in response to parenteral nutrition in male patients with alcoholic liver cirrhosis
🌐 365 Days
AI Virtual Reality Related Evidence Matrix
- Glucose turnover at whole-body and skeletal muscle level in response to parenteral nutrition in male patients with alcoholic liver cirrhosis
- Skeletal muscle protein turnover responses to parenteral nutrition in patients with alcoholic liver cirrhosis and sarcopenia
- Skeletal Muscle Consequences of Phosphatidylethanolamine Synthesis Deficiency
- Fish oil minimizes feed intake and improves insulin sensitivity in Zucker fa/fa rats
- Myosteatosis for Early Detection of Muscle Disorder in Patients With Liver Cirrhosis
- Interesterified palm oil promotes insulin resistance and altered insulin secretion and signaling in Swiss mice
- Depletion of TBC1D4 improves the metabolic exercise response by overcoming genetically induced peripheral insulin resistance
- Mid-arm muscle circumference cutoff points in patients with cirrhosis: Low muscle mass related to malnutrition predicts mortality
- Liver-derived extracellular vesicles improve whole-body glycaemic control via inter-organ communication
- Prevalence of and associated factors for sarcopenia in patients with liver cirrhosis: A systematic review and meta-analysis
- Alcohol blunts pregnancy-mediated insulin resistance and reduces fetal brain glucose despite elevated fetal gluconeogenesis, and these changes associate with fetal weight outcomes
- Pregnane X receptor activation remodels glucose metabolism to promote NAFLD development in obese mice
- Drp1 controls complex II assembly and skeletal muscle metabolism by Sdhaf2 action on mitochondria
- Sarcopenia in cirrhosis: Unraveling the prevalence and relationships with liver disease severity and complications
- Sarcopenia in cirrhosis: Unraveling the prevalence and relationships with liver disease severity and complications
- Muscle fibre morphometric analysis (MusMA) correlates with muscle function and cardiovascular risk prognosis
- Deep RNA sequencing of muscle tissue reveals absence of viral signatures in dermatomyositis
- Celastrol attenuates HFD-induced obesity and improves metabolic function independent of adiponectin signaling
- Clinical Overview of Sarcopenia, Frailty, and Malnutrition in Patients With Liver Cirrhosis
- Adipose Tissue Insulin Resistance in South Asian and Nordic Women after Gestational Diabetes Mellitus
- Insulin resistance and adipose tissue interactions as the cornerstone of metabolic (dysfunction)-associated fatty liver disease pathogenesis
- Extracellular vesicles from obese and diabetic mouse plasma alter C2C12 myotube glucose uptake and gene expression
- In vivo heat production dynamics during a contraction-relaxation cycle in rat single skeletal muscle fibers
- From NAFLD to NASH: Understanding the spectrum of non-alcoholic liver diseases and their consequences
- Delineating the contribution of ageing and physical activity to changes in mitochondrial characteristics across the lifespan
- Overexpression of lncRNA HEM2M alleviates liver injury in mice with non-alcoholic fatty liver disease
- Fat loss and muscle gain: The possible role of cortical glutamate in determining the efficacy of physical exercise
- Long-Term pemafibrate treatment exhibits limited impact on body fat mass in patients with hypertriglyceridemia accompanying NAFLD
- Knockout of STE20-type kinase TAOK3 does not attenuate diet-induced NAFLD development in mice
- Lithium and exercise ameliorate insulin-deficient hyperglycemia by independently attenuating pancreatic α-cell mass and hepatic gluconeogenesis
- Gremlin-1 in pregnancy and postpartum: relation to the fatty liver index, markers of bone health, glucose metabolism and gestational diabetes mellitus status
- Association between suicidal behavior and impaired glucose metabolism in first-episode drug-naïve patients with schizophrenia
- Sex difference in skeletal muscle mass in relation to metabolic dysfunction-associated steatotic liver disease: a propensity score matching study
- Eryngium billardieri extract affects cardiac gene expression of master regulators of cardiomyaopathy in rats with high fatdiet-induced insulin resistance
- The impact of piperine on the metabolic conditions of patients with NAFLD and early cirrhosis: a randomized double-blind controlled trial
- Effects of intermittent fasting regimens on glycemic, hepatic, anthropometric, and clinical markers in patients with non-alcoholic fatty liver disease: Systematic review and meta-analysis of randomized controlled trials
- Loss of NOR-1 represses muscle metabolism through mTORC1-mediated signaling and mitochondrial gene expression in C2C12 myotubes
- Assessment of sarcopenic obesity as a predictor of pneumonia in patients with stable schizophrenia-A prospective study
- Human umbilical cord mesenchymal stem cells attenuate diet-induced obesity and NASH-related fibrosis in mice
- Prevalence and impact on the outcome of myosteatosis in patients with cirrhosis: a systematic review and meta-analysis
- MiR-18 regulates lipid metabolism of non-alcoholic fatty liver disease via IGF1
- Reduced exercise capacity occurs before intrinsic skeletal muscle dysfunction in experimental rat models of pulmonary hypertension
- Effectiveness of the ALT/AST ratio for predicting insulin resistance in a Korean population: A large-scale, cross-sectional cohort study
- Prevalence of nonalcoholic fatty liver disease and liver cirrhosis in Chinese adults with type 2 diabetes mellitus
- The influence of acute lifestyle changes on NAFLD evolution in a multicentre cohort: a matter of body composition
- Sex- and reproductive status-specific relationships between body composition and non-alcoholic fatty liver disease
- Amisulpride as the antipsychotic of choice in severe psychotic disorder with comorbid impaired glucose tolerance
- Effects of 8 weeks of resistance training in combination with a high protein diet on body composition, muscular performance, and markers of liver and kidney function in untrained older ex-military men
- Inflammatory liver diseases and susceptibility to sepsis
- LEAP2 is Associated with Cardiometabolic Markers, but is Unchanged by Antidiabetic Treatment in People with Prediabetes
- Prefrontal cortical dopamine deficit may cause impaired glucose metabolism in schizophrenia
- Ablation of the carboxy-terminal end of MAMDC2 causes a distinct muscular dystrophy
- Blood flow restriction Exercise in the perioperative setting to Prevent loss of muscle mass in patients with pancreatic, biliary tract, and liver cancer: study protocol for the PREV-Ex randomized controlled trial
- Blood flow restriction Exercise in the perioperative setting to Prevent loss of muscle mass in patients with pancreatic, biliary tract, and liver cancer: study protocol for the PREV-Ex randomized controlled trial
- Systematic review of sarcopenia in inflammatory bowel disease
- Muscle Mass Adjusted for Body Weight Is Associated with Significant Liver Fibrosis in Young Adults with Nonalcoholic Fatty Liver Disease: A Cross-Sectional Study from a Korean Military Hospital
- 13C-Stable isotope resolved metabolomics uncovers dynamic biochemical landscape of gut microbiome-host organ communications in mice
- Effect of Zuogui Jiangtang Qinggan Formula on lipid metabolism in db/db mouse model of type 2 diabetes mellitus complicated with non-alcoholic fatty liver disease
- Differences in Fecal Short-Chain Fatty Acids between Alcoholic Fatty Liver-Induced Cirrhosis and Non-alcoholic (Metabolic-Associated) Fatty Liver-Induced Cirrhosis
- Circadian desynchrony and glucose metabolism
- Amphiregulin from regulatory T cells promotes liver fibrosis and insulin resistance in non-alcoholic steatohepatitis
- Measurement plane of the cross-sectional area of the masseter muscle in patients with skeletal Class III malocclusion: An artificial intelligence model
- Efficacy, tolerability and pharmacokinetics of survodutide, a glucagon/glucagon-like peptide-1 receptor dual agonist, in cirrhosis
- Efficacy, tolerability and pharmacokinetics of survodutide, a glucagon/glucagon-like peptide-1 receptor dual agonist, in cirrhosis